Peru's SMV Orders Aspi to Disclose SPA Terms and S/1.85B Valuation in Pacasmayo Tender
CPAC has more than doubled off its 52-week low of $6.25.
Summary
Peru's SMV issued a new observation letter requiring Aspi to disclose the SPA terms, due diligence findings and the S/ 1,850,370,000 valuation behind Holcim's control acquisition in the Pacasmayo tender prospectus, with a three-business-day deadline to cure.
Key Events · M&A and Partnerships · CPAC
-
SMV Issues New Tender Observations
Official Letter No. 5476-2026-SMV/11.1, dated October 28, 2026, tells Inversiones Aspi its OPA documentation for up to 211,882,902 shares (49.99% of Pacasmayo) is insufficient and must be corrected.
-
SPA and Valuation Must Be Disclosed
Aspi must annex an uncertified copy of the SPA with Spanish translation and disclose the S/ 1,850,370,000 total economic value attributed to the 50.01% of Pacasmayo indirectly acquired by Holcim.
-
Due Diligence Summaries Required
The regulator wants the due diligence summaries and a description of material findings and contingencies annexed to the prospectus, information Holcim previously declined to provide on confidentiality grounds.
-
Peru and U.S. Offers Must Align
The Peruvian prospectus must be conformed to the U.S. Offer to Purchase dated October 22, 2026, covering background, fairness position, conflicts of interest and effects of the offers.
Analysis · CPAC · Manufacturing
Peru's regulator is forcing the Holcim/Aspi side to put the economics of the change-of-control transaction in front of Pacasmayo minority holders. The letter demands the SPA, the due diligence summaries and the S/ 1,850,370,000 value attributed to the 50.01% stake be added to the tender prospectus, and requires the Peruvian offer to match the U.S. Offer to Purchase filed October 22, 2026. That matters because the S/ 8.93-per-share offer is being tested against what Holcim actually paid for control; fuller disclosure gives holders a better basis to accept or reject. The three-business-day cure period means the prospectus could be amended within the week, and any change to the offer period or terms needs prior SMV approval.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CPAC was trading at $12.79 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $6.25 to $12.87. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.